Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China

Di Shen,1,* Xintian Cai,2,* Junli Hu,2 Shuaiwei Song,1 Qing Zhu,2 Huimin Ma,2 Yingying Zhang,2 Rui Ma,2 Pan Zhou,2 Wenbo Yang,2 Jing Hong,2 Delian Zhang,2 Nanfang Li2 1Graduate School, Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China; 2Hypertension Center of...

Full description

Saved in:
Bibliographic Details
Main Authors: Shen D, Cai X, Hu J, Song S, Zhu Q, Ma H, Zhang Y, Ma R, Zhou P, Yang W, Hong J, Zhang D, Li N
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/inflammatory-indices-and-mafld-prevalence-in-hypertensive-patients-a-l-peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540581913427968
author Shen D
Cai X
Hu J
Song S
Zhu Q
Ma H
Zhang Y
Ma R
Zhou P
Yang W
Hong J
Zhang D
Li N
author_facet Shen D
Cai X
Hu J
Song S
Zhu Q
Ma H
Zhang Y
Ma R
Zhou P
Yang W
Hong J
Zhang D
Li N
author_sort Shen D
collection DOAJ
description Di Shen,1,* Xintian Cai,2,* Junli Hu,2 Shuaiwei Song,1 Qing Zhu,2 Huimin Ma,2 Yingying Zhang,2 Rui Ma,2 Pan Zhou,2 Wenbo Yang,2 Jing Hong,2 Delian Zhang,2 Nanfang Li2 1Graduate School, Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China; 2Hypertension Center of People’s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, NHC Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, Xinjiang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Nanfang Li, Hypertension Center of People’s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, NHC Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region “Hypertension Research Laboratory”, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, No. 91 Tianchi Road, Urumuqi, Xinjiang, 830001, People’s Republic of China, Tel +86 8564818, Email lnanfang2016@sina.comObjective: Hypertension development and progression are largely influenced by inflammation, which plays a critical role by activating the immune system and causing damage to the vascular endothelium. Metabolic dysfunction-associated fatty liver disease (MAFLD) is also associated with chronic low-grade inflammation, which drives disease progression via metabolic imbalances and adipose tissue dysfunction. This study investigates the relationship between inflammatory indices and MAFLD in hypertensive patients and assesses the predictive accuracy of these indices for MAFLD.Methods: We performed a cross-sectional analysis involving 34,303 hypertensive patients from a Chinese hospital-based registry. The diagnosis of MAFLD was established using metabolic dysfunction criteria alongside evidence of hepatic steatosis confirmed through imaging. Complete blood counts were used to calculate inflammatory indices, including the monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic inflammatory response index (SIRI), systemic immune-inflammation index (SII), and aggregate index of systemic inflammation (AISI). To assess the relationship between inflammatory indices and MAFLD, multivariable logistic regression was performed with adjustments for potential confounders. The diagnostic performance of these indices was analyzed using receiver operating characteristic (ROC) curves and area under the curve (AUC) calculations.Results: Patients with MAFLD exhibited significantly elevated levels of all inflammatory indices compared to those without. After multivariable adjustment, each standard deviation increase in AISI, SIRI, and SII was associated with a 74%, 62%, and 58% increased odds of MAFLD, respectively. The AUC for AISI was 0.659, indicating moderate diagnostic accuracy. The AUCs for SIRI and SII were 0.626 and 0.619, respectively, while NLR, PLR, and MLR had lower AUCs of 0.593, 0.558, and 0.589, respectively.Conclusion: In hypertensive patients, inflammatory indices, especially AISI, show a strong association with MAFLD, indicating their potential utility in risk stratification within clinical settings. Further research is needed to evaluate the effectiveness of these markers in the management of MAFLD. Keywords: metabolic-dysfunction-associated fatty liver disease, inflammatory indices, hypertension, diagnostic accuracy
format Article
id doaj-art-2555dcc4cb71490ab82c496caccf7433
institution Kabale University
issn 1178-7031
language English
publishDate 2025-02-01
publisher Dove Medical Press
record_format Article
series Journal of Inflammation Research
spelling doaj-art-2555dcc4cb71490ab82c496caccf74332025-02-04T17:15:41ZengDove Medical PressJournal of Inflammation Research1178-70312025-02-01Volume 181623163899892Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from ChinaShen DCai XHu JSong SZhu QMa HZhang YMa RZhou PYang WHong JZhang DLi NDi Shen,1,* Xintian Cai,2,* Junli Hu,2 Shuaiwei Song,1 Qing Zhu,2 Huimin Ma,2 Yingying Zhang,2 Rui Ma,2 Pan Zhou,2 Wenbo Yang,2 Jing Hong,2 Delian Zhang,2 Nanfang Li2 1Graduate School, Xinjiang Medical University, Urumqi, Xinjiang, People’s Republic of China; 2Hypertension Center of People’s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, NHC Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, Xinjiang, People’s Republic of China*These authors contributed equally to this workCorrespondence: Nanfang Li, Hypertension Center of People’s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, NHC Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region “Hypertension Research Laboratory”, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, No. 91 Tianchi Road, Urumuqi, Xinjiang, 830001, People’s Republic of China, Tel +86 8564818, Email lnanfang2016@sina.comObjective: Hypertension development and progression are largely influenced by inflammation, which plays a critical role by activating the immune system and causing damage to the vascular endothelium. Metabolic dysfunction-associated fatty liver disease (MAFLD) is also associated with chronic low-grade inflammation, which drives disease progression via metabolic imbalances and adipose tissue dysfunction. This study investigates the relationship between inflammatory indices and MAFLD in hypertensive patients and assesses the predictive accuracy of these indices for MAFLD.Methods: We performed a cross-sectional analysis involving 34,303 hypertensive patients from a Chinese hospital-based registry. The diagnosis of MAFLD was established using metabolic dysfunction criteria alongside evidence of hepatic steatosis confirmed through imaging. Complete blood counts were used to calculate inflammatory indices, including the monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic inflammatory response index (SIRI), systemic immune-inflammation index (SII), and aggregate index of systemic inflammation (AISI). To assess the relationship between inflammatory indices and MAFLD, multivariable logistic regression was performed with adjustments for potential confounders. The diagnostic performance of these indices was analyzed using receiver operating characteristic (ROC) curves and area under the curve (AUC) calculations.Results: Patients with MAFLD exhibited significantly elevated levels of all inflammatory indices compared to those without. After multivariable adjustment, each standard deviation increase in AISI, SIRI, and SII was associated with a 74%, 62%, and 58% increased odds of MAFLD, respectively. The AUC for AISI was 0.659, indicating moderate diagnostic accuracy. The AUCs for SIRI and SII were 0.626 and 0.619, respectively, while NLR, PLR, and MLR had lower AUCs of 0.593, 0.558, and 0.589, respectively.Conclusion: In hypertensive patients, inflammatory indices, especially AISI, show a strong association with MAFLD, indicating their potential utility in risk stratification within clinical settings. Further research is needed to evaluate the effectiveness of these markers in the management of MAFLD. Keywords: metabolic-dysfunction-associated fatty liver disease, inflammatory indices, hypertension, diagnostic accuracyhttps://www.dovepress.com/inflammatory-indices-and-mafld-prevalence-in-hypertensive-patients-a-l-peer-reviewed-fulltext-article-JIRmetabolic-dysfunction-associated fatty liver diseaseinflammatory indiceshypertensiondiagnostic accuracy
spellingShingle Shen D
Cai X
Hu J
Song S
Zhu Q
Ma H
Zhang Y
Ma R
Zhou P
Yang W
Hong J
Zhang D
Li N
Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China
Journal of Inflammation Research
metabolic-dysfunction-associated fatty liver disease
inflammatory indices
hypertension
diagnostic accuracy
title Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China
title_full Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China
title_fullStr Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China
title_full_unstemmed Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China
title_short Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China
title_sort inflammatory indices and mafld prevalence in hypertensive patients a large scale cross sectional analysis from china
topic metabolic-dysfunction-associated fatty liver disease
inflammatory indices
hypertension
diagnostic accuracy
url https://www.dovepress.com/inflammatory-indices-and-mafld-prevalence-in-hypertensive-patients-a-l-peer-reviewed-fulltext-article-JIR
work_keys_str_mv AT shend inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT caix inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT huj inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT songs inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT zhuq inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT mah inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT zhangy inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT mar inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT zhoup inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT yangw inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT hongj inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT zhangd inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina
AT lin inflammatoryindicesandmafldprevalenceinhypertensivepatientsalargescalecrosssectionalanalysisfromchina